老年冠心病抑郁状态与社会心理因素及IL-17变化的相关性研究
|
摘要
目的:
①探讨老年冠心病抑郁状态患病情况及危险因素。
②探讨炎症细胞因子白细胞介素-17(IL-17)及炎性标志物C反应蛋白(CRP)与老年冠心病抑郁状态的相关性。
③了解综合干预对老年冠心病抑郁状态患者抑郁状况、生活质量及心肌缺血的影响。
方法:
①利用自制调查表、汉密顿量表、日常生活能力量表及社会支持评定表,采用面对面访谈方式收集资料,随机抽取长沙市望月湖、陈家湖、广济桥三个社区,调查了332例老年冠心病患者。
②随机抽取38例老年冠心病抑郁状态患者及30例老年冠心病非抑郁状态患者作为研究对象,用夹心酶联免疫吸附法检测血浆白细胞介素-17和C反应蛋白浓度,用逆转录聚合酶链反应(RT-PCR)技术检测单核细胞白细胞介素-17表达情况。
③随机抽取96例老年冠心病抑郁状态患者,分别进行综合干预(n=50)及药物治疗(n=46),,观察综合干预对老年冠心病抑郁状态的影响。
结果:
①老年冠心病患者332例,其中男性183例,女性149例。332例中抑郁状态患者152例,抑郁状态发生率为45.8%,女性发生率为48.9%,高于男性43.2%(P<0.05)。女性、年龄、文化程度低、日常生活不能完全自理增加患者抑郁风险,相应OR值分别为1.48、1.69、2.154、8.92(P均<0.05)。抑郁组主观支持评分及对支持利用度评分均低于对照组(P均<0.05)。
②老年冠心病抑郁状态患者血浆IL-17、CRP浓度及单核细胞IL-17表达明显高于对照组(P均<0.01),老年冠心病抑郁状态患者血浆IL-17、CRP浓度随抑郁程度的加重而升高(P均<0.05)。老年冠心病抑郁状态患者血浆CRP浓度与IL-17浓度呈正相关(P<0.05):老年冠心病抑郁状态患者中,急性冠脉综合征合并抑郁组CRP、IL-17浓度及单核细胞IL-17mRNA均高于稳定型心绞痛合并抑郁组(P<0-01)。
③综合干预与药物治疗组在HAMD评分、SAQ评分及ST段压低次数和持续时间方面较治疗前均明显改善(P均<0.05),综合干预组与药物治疗组疗效相当。
结论:
①对长沙市社区进行调查发现,老年冠心病患者抑郁状态发生率为45.8%,女性患病率高于男性;女性、年龄、文化程度低、生活不能完全自理及社会支持降低等与抑郁状态的发生有关。
②白细胞介素-17及C反应蛋白在老年冠心病抑郁状态患者的炎性发病机理中可能起一定的作用,但其因果关系尚不能完全明了。
③综合干预能减轻老年冠心病患者抑郁症状,提高患者生活质量,改善心绞痛症状。
第一章老年冠心病抑郁状态与社会心理因素相关性分析
目的:
探讨老年冠心病抑郁的患病情况及危险因素
方法:
采用横断面调查的方法,于2006年7月至2008年2月对长沙市望月湖、陈家湖、广济桥三个社区的老年人进行调查,随机抽取冠心病患者332例,由经过培训的调查员使用统一的调查表进行入户面对面调查,调查表包括汉密顿量表'(HAMD)、日常生活能力量表、社会支持评定量表及自制调查表进行测评。
结果:
①332例对象中抑郁状态患者152例(45.8%),其中轻至中度抑郁状态者115例(34.6%),重度抑郁状态者37例(11.2%)。
②70岁年龄组抑郁状态发生率高于60岁年龄组(分别为55.8%、36.9%,P<0.05)。
③老年女性抑郁状态发生率高于老年男性(分别为48.9%、43.2%,P<0.05)。
④女性、年龄、文化程度低、日常生活不能完全自理增加患者抑郁风险性,相应OR值分别为1.48、1.69、2.154、8.92。P均<0.05
⑤抑郁状态组主观支持评分(15.0±3.9)及对支持利用度评分(6.4±2.0)均低于非抑郁状态组(分别为22.6±4.0 8.0±2.9,P均<0.05)。
⑥客观支持评分、主观支持评分对及支持利用度评分与HAMD总分不相关(r分别为0.125、0.132、0.218,P均>0.05)。
结论:
老年冠心病患者抑郁状态发生率高;年龄增加,发生率增高;女性患病率高于男性;文化程度低、日常生活不能完全自理、社会支持降低与抑郁状态的发生有关。
第二章老年冠心病抑郁状态患者白细胞介素-17和C反应蛋白的变化
目的:
探讨老年冠心病抑郁状态患者血浆白细胞介素-17浓度及单核细胞白细胞介素-17表达的变化和血浆C反应蛋白浓度的变化。
方法:
随机抽取38例老年冠心病抑郁状态患者做为研究对象,30例老年冠心病非抑郁状态患者为对照组,采用夹心酶联免疫吸附法(ELISA)检测血浆中白细胞介素-17及C反应蛋白浓度,采用逆转录聚合酶链反应(RT-PCR)技术观察单核细胞IL-17表达。
结果:
①老年冠心病抑郁状态组患者血浆IL-17、CRP浓度明显高于对照组(323.96±97.15 pg/ml、214.30±58.08 pg/ml,P<0.01)、(4.86±1.32ng/ml、2.16±0.69ng/ml,P<0.01);老年冠心病抑郁状态患者单核细胞IL-17表达明显高于对照组(0.55±0.14,0.26±0.08,P<0.01)
②老年冠心病抑郁状态患者中,急性冠脉综合征合并抑郁状态组血浆IL-17、CRP浓度及单核细胞IL-17mRNA表达均明显高于稳定型心绞痛合并抑郁状态组(分别为372.67±91.39 pg/ml、284.57±84.45pg/ml;5.51±1.36ng/ml、4.28±1.01ng/ml;0.62±0.19、0.49±0.13。P均<0.01)。
③老年冠心病抑郁状态组中,重度抑郁状态患者血浆IL-17明显高于轻-中度抑郁状态患者组(395.42±128.75pg/ml,310.27±96.35pg/ml,p<0.01)。重度抑郁状态患者血浆CRP浓度明显高于轻-中度抑郁状态组(4.90±1.38ng/ml,4.10±1.25ng/ml,p<0.01),重度抑郁状态患者单核细胞IL-17mRNA的表达明显高于轻-中度抑郁状态患者(0.61±0.22,0.48±0.13,p<0.01)。
④老年冠心病抑郁状态组中,急性冠脉综合征患者重度抑郁比例高于稳定型心绞痛患者重度抑郁比例(P<0.05)。
⑤老年冠心病抑郁状态组血浆CRP浓度与血浆IL-17浓度呈显著正相关(r=0.802,p<0.05),血浆IL-17及CRP浓度与抑郁评分呈正相关(r=0.672,P<0.05;r=0.421,P<0.05)。
结论:
白细胞介素-17及C反应蛋白在老年冠心病抑郁状态的发病机理中可能起重要的作用。
第三章综合干预对老年冠心病抑郁状态患者生活质量的影响
目的:
对老年冠心病抑郁状态患者进行综合干预,观察综合干预对老年冠心病抑郁状态患者抑郁状况、生活质量的改善情况以及心肌缺血改善的效果。
方法:
选择老年冠心病抑郁患者96例,随机分为综合干预组(n=50)、药物治疗组(n=46)。二组患者均给予常规治疗,如硝酸盐类、β受体阻滞剂、钙离子拮抗剂、抗凝、抗血小板、调脂等治疗。药物治疗组在常规药物治疗基础上加用盐酸舍曲林(左洛复50mg Qd,辉瑞制药有限公司)。综合干预组采用综合干预措施进行干预。
结果:
①综合干预组及药物治疗组干预后HAMD、SAQ评分及ST段改变方面均有改善。综合干预组及药物治疗组HAMD评分较干预前明显改善(分别为17.87±5.38 VS 28.72±7.54,18.72±6.19 VS27.85±8.27,P均<0.01);活动受限程度评分较干预前均明显改善(32.32±8.67 VS 26.58±5.30,33.28±7.95 VS 27.32±5.47,P均<0.01)。治疗满意程度评分较干预前均明显改善(16.39±4.83 VS14.20±2.64,16.31±5.07 VS 13.98±4.02,P均<0.01);SAQ总分较干预前明显改善(80.25±25.32 VS 62.1 9±12.35,83.27±27.12 VS 63.07±13.54,P均<0.01);心绞痛发作情况评分较干预前明显改善(8.19±2.45 VS 7.05±2.35,8.06±2.63 VS 6.97±2.18,P均<0.05);疾病认识程度评分较干预前明显改善(12.28±4.03 VS 10.07±2.85,12.01±3.96 VS 9.98±2.91,P均<0.05);ST段压低次数较干预前明显改善(32.5±12.7 VS 84.3±13.8,31.9±13.9 VS 82.2±15.7,P均<0.05);ST段压低持续时间较干预前明显减少(88.4±28.7 VS 172.5±32.8,89.5±32.7 VS176.3±36.4,P均<0.01)。心绞痛稳定状态评分较干预前无统计学意义(3.52±0.87 VS 3.02±1.27 3.47±0.95 VS 2.95±1.15.P均>0.05)。
②干预后,综合干预组及药物治疗组HAMD评分差值比较无统计学意义(9.03±3.15,9.35±3.01,P>0.05);疾病认识程度评分、活动受限程度评分、心绞痛发作情况评分、治疗满意程度评分、心绞痛稳定状态评分及SAQ总分差值比较均无统计学意义(分别为2.32±0.67 VS 2.28±0.65,6.32±1.81 VS 6.10±2.05,1.17±0.38 VS 1.08±0.29,2.13±0.68 VS 2.09±0.63,0.52±0.17 VS 0.49±0.16,19.98±6.56 VS 19.75±6.72,P均>0.05);ST段压低次数及ST段压低持续时间差值比较无统计学(50.08±16.75 VS 50.75±17.36,92.75±31.26 VS 88.75±30.92,P均>0.05)。
结论:
综合干预能减轻老年冠心病抑郁状态患者抑郁症状,提高患者生活质量,改善心绞痛症状。
Objectives:
①To explore the risk factors and morbility of depression in aging patients with coronary heart disease.
②To evalute changes of the level of IL-17 and CRP in plasma of aging coronary heart disease with depression and expression of IL-17 in monocytes of these patients.
③To know the role of comprehensive intervention to aging coronary heart disease with depression in depressive systom,quality of life and ischemia of myocardium.
Methods:
①A cross-sectional study was conducted in three communities of Wangyuehu,Chengjiahu,Guangjiqiao.322 aging CHD patients were selected.Face to face interview was used in data collection together with the HAMD,social support rating scales and self-made scales.The data were analysis in spss 15.0.
②We analyzed the levels of IL-17 and CRP in plasma using enzyme-linked immunosorbent assay and expression of IL-17 in monocytes using RT-PCR in 68 patients divided into two groups. Depression group(n＝38)and un-depression group(n＝30).
③The 96 depressive aging patients with coronary heart disease were alloted into comprehensive intervention group(n＝50),Drug therapy group(n＝46).We observed the effect of comprehensive intervention on depressive system,quality of life and ischemia of myocardium.
Results:
①The prevalence of depression in aging coronary heart disease was 45.8%in 332 patients.The prevalence of female patients is higher than that of male patients(48.9%vs 43.2%).Female,aging,lower degree culture and non-ambulatory patients had higher risk of depression with OR at 1.48,1.69,2.154,8.92.(all P＜0.05).Subjective support scores and utilized degree to support scores of depression groups were all higher than that of the control group(all P＜0.05).
②Concentrations of IL-17 and CRP and expression of IL-17 in monocytes of aging coronary heart disease with depressive status were significantly higher than that of the control group(all P＜0.01).Concentrations of IL-17 and CRP were positively related to scores of HAMD(P＜0.05).Concentrations of IL-17 were positively related to CRP in plasma in aging coronary heart disease patients with depressive status(P＜0.05).Leves of CRP and IL-17 and expression of IL-17 in monocytes in acute coronary syndrom acccompanied depressive status were higher than those of stable angina acompanied depression(all P＜0.01).
③Comprehensive intervention and drug therapy could improve scores of HAMD,scores of SAQ,frequency of ST depression and time of ST depression compared to treatment before(all P＜0.05).the effect of comprehensive intervention was the same as drug therapy.
Conclusions:
①we investigated conditions of aging coronary artery disease patients with depression in changsha for the first time.The results indicated that the prevalence of depression in aging patients with coronary heart disease was high.The prevalence of female patients was higherthan that of male patients.Female,aging,lower degree of culture, non-ambulatory and lower social support were correlation with depressive status.
②For the first time we found that interleukin-17 and C-reactive protein may play an important role in the mechanism of aging coronary heart diseasewith depression.
③Comprehensive intervention can lighten depressive systoms, elevate quality of life and improve symptoms of angina
Chapter 1 Analysis of relationship between depressive
status and psychosocial factors in aging coronary heart
disease
Objective:
To explore the risk factors and morbility of depression in aging patients with coronary heart disease(CHD)。
Methods:
A cross-sectional study was conducted in communities of wang yuehu,Chenjiahu and Guangjiqiao in changsha from June in 2006 to Feburary in 2008.332 CHD patients were selected randomly.Face to face interview was used in data collection together with the HAMD,social support rating scales and investigate scales self-made.Multinomial Logistic Model was adopted in date analysis.
Results:
①Among 332 patients,152 patients suffered from depression (45.8%).115 patients(34.6%) were minor to middle depressive disorders and 37 patients(11.2%) were major depression.
②The prevalence,of depressive status in 70-year group was higher than that of 60-year group(55.8%VS 36.9%,P＜0.05).
③The prevalence of depressive status in female aging patients was higher than that of male aging patients(48.9%VS 43.2%,P＜0.05).
④Female,age,lower culture degree and non-ambulatory patients had a statistically higher risk of depression with the OR at 1.48,1.69, 2.154,8.92,(all P＜0.05)
⑤Subjective support scores and utilized degree to support scores of depressive stares groups were all higher than that of non-depressive status groups(15.0±3.9 VS 22.6±4.0,6.4±2.0 VS 8.0±2.0,respectively,all P＜0.05).
⑥Objective support scores,subjective support scores and utilized degree to support scores were not correlation with HAMD scores.
Conclusion:
It was noticeable that the prevalence of depressive status in patients of aging coronary heart disease was high.With aging increasing,the prevalence increased,The prevalence of depressive status in female patients were higher than that of men patients.Low culture level, non-ambulatory patients and low social support were associated with depressive status.
Chapter 2 Changes of interleukin-17 and C-reactive protein
in aging coronary heart disease patients with depressive
status
Objective:
The aim was to evaluate levels of IL-17 and CRP in plasma of aging coronary heart disease patients with depressive status and expression of IL-17 in monocytes of these patients.
Methods:
We analyzed the concentrations of IL-17 and CRP in plasma using enzym-linked immunosorbent assay and expression of IL-17 in monocytes using RT-PCR in 68 selected patient randomly divided into two groups,depressive status group(n＝38)and un-depressive status group(n＝30).
Results:
①Concentrations of IL-17 and CRP were significantly higher in aging depressive status patient with coronary heart disease than those of the control group(323.96±97.15 pg/ml VS 214.30±58.08 pg/ml,4.86±1.32 ng/ml VS 2.16±0.69ng/ml,all P＜0.01).Expression of IL-17 in monocytes of aging depressive status with coronary heart disease were higher than that of the control group(0.55±0.14,0.26±0.08,P＜0.01).
②In aging coronary heart disease patients with depressive status group,levels of IL-17 and CRP and expressions of IL-17 in monocytes in acute coronary syndrome accompanied depressive status group were higher than those of stable angina accompanied depressive status group. (372.67±91.39 pg/ml VS 284.57±84.45 pg/ml,5.51±1.36ng/ml VS 4.28±1.01 ng/ml,0.62±0.19 VS 0.49±0.13,all P＜0.01)
③In aging coronary heart disease patients depressive status group concentrations of IL-17 major depressive status patients were significantly higher than those of minor to moderate depressive status patients(395.42±128.75pg/ml,310.27±96.35pg/ml p＜0.01).The plasma levels of CRP in aging coronary heart disease patients with major depression status were increased as compared,with minor to moderate depressive status patients(4.90±1.38ng/ml,4.10±1.25ng/ml,P＜0.01). Expression of IL-17 in monocyte of aging coronary heart disease with major depressive status were elevated as compared with minor to moderate depressive status patients(0.61±0.22,0.48±0.13, P＜0.01).Expression of IL-17 in the major depression patients were higher than that of the minor to moderate depression patients,(P＜0.05).
④The prevalence of major depressive status in acute coronary syndrome was higher than that in stable angina in aging coronary heart disease patients with depressive status(P＜0.05).
⑤The levels of CRP were positively related with IL-17 in aging coronary heart disease patients with depressive status (r＝0.802,P＜0.05).The concentration of IL-17 and CRP were positively associated with the scores of HAMD(r＝0.672,P＜0.05,r＝0.421,P＜0.05).
Conclusion:
Interleukin-17 and C-reactive protein are play an important role in the mechanism of aging coronary heart disease with depressive status.
Chapter 3 The effect of comprehensive intervention on
quality of life of aging coronary heart disease patients
with depressive status
Objective:
To study whether comprehensive intervention for depression in aging patients with coronary heart disease(CHD) can or not lead to some improvement in depressive symptoms,quality of life and ischemia of myocardium.
Methods:
96 depressive status aging patients with coronary heart disease were alloted into comprehensive intervention group(n＝50),drug treatment group(n＝46)randomly.Patients received comprehensive intervention and anti-depressant serotonin HCIz(zoloft,Pfizer50mg qd) on the basis of conventional cardiac medicine therapy for 12 weeks in the comprehensive intervention group and drug therapy,respectively.
Results:
①After treatment scores of HAMD and SAQ and change of ST were improvement in comprehensive intervention group and drug treatment group.Scores of HAMD were lower than treatment before(17.85±5.38 VS 28.72±7.54,18.72±6.17 VS 27.85±8.27,respectively,all P＜0.01)in the two groups.Scores of activate restriction were higher than treatment before(32.32±8.67 VS 26.58±5.30,33.28±7.95 VS 27.32±5.47,all P＜0.01)in the two groups,Scores of contest degree were higher than treatment before(16.39±4.83 VS 14.20±2.64,16.31±5.07 VS 13.98±4.02,all P＜0.01)in the two groups.Total scores of SAQ were higher than treatment before(80.25±25.32 VS 62.19±12.35,83.27±27.12 VS 63.07±13.54,all P＜0.01),Score of angina attack were higher than treatment before(8.19±2.45 VS 7.05±2.35,8.06±2.63 VS 6.97±2.18,all P＜0.05).Frequency of ST depression were lower than treatment before(32.5±12.7 VS 84.3±13.8, 31.9±13.9 VS 82.2±15.7,all P＜0.05).Times of ST depression were lower than treatment before(88.4±28.7 VS 172.5±32.8,89.5±32.7 VS 176.3±36.4,all P＜0.01).There were no difference in the scores of angina stability between treatment before and.after treatment in two. group(3.52±0.87 VS 3.02±1.27,3.47±0.95 VS 2.95±1.15,all P＞0.05).
②There were no difference in scores difference of HAMD among the two groups after treatment(9.03±3.15,9.35±3.01,P＞0.05).There were no difference in scores difference of degree to recognizing disease,activate restriction,angina attack,content degree,angina stability and total SAQ among the two groups(2.32±0.67 VS 2.28±0.65,6.32±1.81 VS 6.10±2.05,1.17±0.38 VS 1.08±0.29,2.13±0.68 VS 2.09±0.63,0.52±0.17 VS 0.49±0.16,19.98±6.56 VS 19.75±6.72 respectively,all P＞0.05).There were no difference in difference of frequency and times of ST depression among the two groups(50.08±16.75 VS 50.75±17.36, 92.75±31.26 VS 88.75±30.92,respectively,all P＞0.05).
Conclusion:
Comprehensive intervention can relieve depressive symptoms,improve quality of life and improve anginal symptoms.
①探讨老年冠心病抑郁状态患病情况及危险因素。
②探讨炎症细胞因子白细胞介素-17(IL-17)及炎性标志物C反应蛋白(CRP)与老年冠心病抑郁状态的相关性。
③了解综合干预对老年冠心病抑郁状态患者抑郁状况、生活质量及心肌缺血的影响。
方法:
①利用自制调查表、汉密顿量表、日常生活能力量表及社会支持评定表,采用面对面访谈方式收集资料,随机抽取长沙市望月湖、陈家湖、广济桥三个社区,调查了332例老年冠心病患者。
②随机抽取38例老年冠心病抑郁状态患者及30例老年冠心病非抑郁状态患者作为研究对象,用夹心酶联免疫吸附法检测血浆白细胞介素-17和C反应蛋白浓度,用逆转录聚合酶链反应(RT-PCR)技术检测单核细胞白细胞介素-17表达情况。
③随机抽取96例老年冠心病抑郁状态患者,分别进行综合干预(n=50)及药物治疗(n=46),,观察综合干预对老年冠心病抑郁状态的影响。
结果:
①老年冠心病患者332例,其中男性183例,女性149例。332例中抑郁状态患者152例,抑郁状态发生率为45.8%,女性发生率为48.9%,高于男性43.2%(P<0.05)。女性、年龄、文化程度低、日常生活不能完全自理增加患者抑郁风险,相应OR值分别为1.48、1.69、2.154、8.92(P均<0.05)。抑郁组主观支持评分及对支持利用度评分均低于对照组(P均<0.05)。
②老年冠心病抑郁状态患者血浆IL-17、CRP浓度及单核细胞IL-17表达明显高于对照组(P均<0.01),老年冠心病抑郁状态患者血浆IL-17、CRP浓度随抑郁程度的加重而升高(P均<0.05)。老年冠心病抑郁状态患者血浆CRP浓度与IL-17浓度呈正相关(P<0.05):老年冠心病抑郁状态患者中,急性冠脉综合征合并抑郁组CRP、IL-17浓度及单核细胞IL-17mRNA均高于稳定型心绞痛合并抑郁组(P<0-01)。
③综合干预与药物治疗组在HAMD评分、SAQ评分及ST段压低次数和持续时间方面较治疗前均明显改善(P均<0.05),综合干预组与药物治疗组疗效相当。
结论:
①对长沙市社区进行调查发现,老年冠心病患者抑郁状态发生率为45.8%,女性患病率高于男性;女性、年龄、文化程度低、生活不能完全自理及社会支持降低等与抑郁状态的发生有关。
②白细胞介素-17及C反应蛋白在老年冠心病抑郁状态患者的炎性发病机理中可能起一定的作用,但其因果关系尚不能完全明了。
③综合干预能减轻老年冠心病患者抑郁症状,提高患者生活质量,改善心绞痛症状。
第一章老年冠心病抑郁状态与社会心理因素相关性分析
目的:
探讨老年冠心病抑郁的患病情况及危险因素
方法:
采用横断面调查的方法,于2006年7月至2008年2月对长沙市望月湖、陈家湖、广济桥三个社区的老年人进行调查,随机抽取冠心病患者332例,由经过培训的调查员使用统一的调查表进行入户面对面调查,调查表包括汉密顿量表'(HAMD)、日常生活能力量表、社会支持评定量表及自制调查表进行测评。
结果:
①332例对象中抑郁状态患者152例(45.8%),其中轻至中度抑郁状态者115例(34.6%),重度抑郁状态者37例(11.2%)。
②70岁年龄组抑郁状态发生率高于60岁年龄组(分别为55.8%、36.9%,P<0.05)。
③老年女性抑郁状态发生率高于老年男性(分别为48.9%、43.2%,P<0.05)。
④女性、年龄、文化程度低、日常生活不能完全自理增加患者抑郁风险性,相应OR值分别为1.48、1.69、2.154、8.92。P均<0.05
⑤抑郁状态组主观支持评分(15.0±3.9)及对支持利用度评分(6.4±2.0)均低于非抑郁状态组(分别为22.6±4.0 8.0±2.9,P均<0.05)。
⑥客观支持评分、主观支持评分对及支持利用度评分与HAMD总分不相关(r分别为0.125、0.132、0.218,P均>0.05)。
结论:
老年冠心病患者抑郁状态发生率高;年龄增加,发生率增高;女性患病率高于男性;文化程度低、日常生活不能完全自理、社会支持降低与抑郁状态的发生有关。
第二章老年冠心病抑郁状态患者白细胞介素-17和C反应蛋白的变化
目的:
探讨老年冠心病抑郁状态患者血浆白细胞介素-17浓度及单核细胞白细胞介素-17表达的变化和血浆C反应蛋白浓度的变化。
方法:
随机抽取38例老年冠心病抑郁状态患者做为研究对象,30例老年冠心病非抑郁状态患者为对照组,采用夹心酶联免疫吸附法(ELISA)检测血浆中白细胞介素-17及C反应蛋白浓度,采用逆转录聚合酶链反应(RT-PCR)技术观察单核细胞IL-17表达。
结果:
①老年冠心病抑郁状态组患者血浆IL-17、CRP浓度明显高于对照组(323.96±97.15 pg/ml、214.30±58.08 pg/ml,P<0.01)、(4.86±1.32ng/ml、2.16±0.69ng/ml,P<0.01);老年冠心病抑郁状态患者单核细胞IL-17表达明显高于对照组(0.55±0.14,0.26±0.08,P<0.01)
②老年冠心病抑郁状态患者中,急性冠脉综合征合并抑郁状态组血浆IL-17、CRP浓度及单核细胞IL-17mRNA表达均明显高于稳定型心绞痛合并抑郁状态组(分别为372.67±91.39 pg/ml、284.57±84.45pg/ml;5.51±1.36ng/ml、4.28±1.01ng/ml;0.62±0.19、0.49±0.13。P均<0.01)。
③老年冠心病抑郁状态组中,重度抑郁状态患者血浆IL-17明显高于轻-中度抑郁状态患者组(395.42±128.75pg/ml,310.27±96.35pg/ml,p<0.01)。重度抑郁状态患者血浆CRP浓度明显高于轻-中度抑郁状态组(4.90±1.38ng/ml,4.10±1.25ng/ml,p<0.01),重度抑郁状态患者单核细胞IL-17mRNA的表达明显高于轻-中度抑郁状态患者(0.61±0.22,0.48±0.13,p<0.01)。
④老年冠心病抑郁状态组中,急性冠脉综合征患者重度抑郁比例高于稳定型心绞痛患者重度抑郁比例(P<0.05)。
⑤老年冠心病抑郁状态组血浆CRP浓度与血浆IL-17浓度呈显著正相关(r=0.802,p<0.05),血浆IL-17及CRP浓度与抑郁评分呈正相关(r=0.672,P<0.05;r=0.421,P<0.05)。
结论:
白细胞介素-17及C反应蛋白在老年冠心病抑郁状态的发病机理中可能起重要的作用。
第三章综合干预对老年冠心病抑郁状态患者生活质量的影响
目的:
对老年冠心病抑郁状态患者进行综合干预,观察综合干预对老年冠心病抑郁状态患者抑郁状况、生活质量的改善情况以及心肌缺血改善的效果。
方法:
选择老年冠心病抑郁患者96例,随机分为综合干预组(n=50)、药物治疗组(n=46)。二组患者均给予常规治疗,如硝酸盐类、β受体阻滞剂、钙离子拮抗剂、抗凝、抗血小板、调脂等治疗。药物治疗组在常规药物治疗基础上加用盐酸舍曲林(左洛复50mg Qd,辉瑞制药有限公司)。综合干预组采用综合干预措施进行干预。
结果:
①综合干预组及药物治疗组干预后HAMD、SAQ评分及ST段改变方面均有改善。综合干预组及药物治疗组HAMD评分较干预前明显改善(分别为17.87±5.38 VS 28.72±7.54,18.72±6.19 VS27.85±8.27,P均<0.01);活动受限程度评分较干预前均明显改善(32.32±8.67 VS 26.58±5.30,33.28±7.95 VS 27.32±5.47,P均<0.01)。治疗满意程度评分较干预前均明显改善(16.39±4.83 VS14.20±2.64,16.31±5.07 VS 13.98±4.02,P均<0.01);SAQ总分较干预前明显改善(80.25±25.32 VS 62.1 9±12.35,83.27±27.12 VS 63.07±13.54,P均<0.01);心绞痛发作情况评分较干预前明显改善(8.19±2.45 VS 7.05±2.35,8.06±2.63 VS 6.97±2.18,P均<0.05);疾病认识程度评分较干预前明显改善(12.28±4.03 VS 10.07±2.85,12.01±3.96 VS 9.98±2.91,P均<0.05);ST段压低次数较干预前明显改善(32.5±12.7 VS 84.3±13.8,31.9±13.9 VS 82.2±15.7,P均<0.05);ST段压低持续时间较干预前明显减少(88.4±28.7 VS 172.5±32.8,89.5±32.7 VS176.3±36.4,P均<0.01)。心绞痛稳定状态评分较干预前无统计学意义(3.52±0.87 VS 3.02±1.27 3.47±0.95 VS 2.95±1.15.P均>0.05)。
②干预后,综合干预组及药物治疗组HAMD评分差值比较无统计学意义(9.03±3.15,9.35±3.01,P>0.05);疾病认识程度评分、活动受限程度评分、心绞痛发作情况评分、治疗满意程度评分、心绞痛稳定状态评分及SAQ总分差值比较均无统计学意义(分别为2.32±0.67 VS 2.28±0.65,6.32±1.81 VS 6.10±2.05,1.17±0.38 VS 1.08±0.29,2.13±0.68 VS 2.09±0.63,0.52±0.17 VS 0.49±0.16,19.98±6.56 VS 19.75±6.72,P均>0.05);ST段压低次数及ST段压低持续时间差值比较无统计学(50.08±16.75 VS 50.75±17.36,92.75±31.26 VS 88.75±30.92,P均>0.05)。
结论:
综合干预能减轻老年冠心病抑郁状态患者抑郁症状,提高患者生活质量,改善心绞痛症状。
Objectives:
①To explore the risk factors and morbility of depression in aging patients with coronary heart disease.
②To evalute changes of the level of IL-17 and CRP in plasma of aging coronary heart disease with depression and expression of IL-17 in monocytes of these patients.
③To know the role of comprehensive intervention to aging coronary heart disease with depression in depressive systom,quality of life and ischemia of myocardium.
Methods:
①A cross-sectional study was conducted in three communities of Wangyuehu,Chengjiahu,Guangjiqiao.322 aging CHD patients were selected.Face to face interview was used in data collection together with the HAMD,social support rating scales and self-made scales.The data were analysis in spss 15.0.
②We analyzed the levels of IL-17 and CRP in plasma using enzyme-linked immunosorbent assay and expression of IL-17 in monocytes using RT-PCR in 68 patients divided into two groups. Depression group(n＝38)and un-depression group(n＝30).
③The 96 depressive aging patients with coronary heart disease were alloted into comprehensive intervention group(n＝50),Drug therapy group(n＝46).We observed the effect of comprehensive intervention on depressive system,quality of life and ischemia of myocardium.
Results:
①The prevalence of depression in aging coronary heart disease was 45.8%in 332 patients.The prevalence of female patients is higher than that of male patients(48.9%vs 43.2%).Female,aging,lower degree culture and non-ambulatory patients had higher risk of depression with OR at 1.48,1.69,2.154,8.92.(all P＜0.05).Subjective support scores and utilized degree to support scores of depression groups were all higher than that of the control group(all P＜0.05).
②Concentrations of IL-17 and CRP and expression of IL-17 in monocytes of aging coronary heart disease with depressive status were significantly higher than that of the control group(all P＜0.01).Concentrations of IL-17 and CRP were positively related to scores of HAMD(P＜0.05).Concentrations of IL-17 were positively related to CRP in plasma in aging coronary heart disease patients with depressive status(P＜0.05).Leves of CRP and IL-17 and expression of IL-17 in monocytes in acute coronary syndrom acccompanied depressive status were higher than those of stable angina acompanied depression(all P＜0.01).
③Comprehensive intervention and drug therapy could improve scores of HAMD,scores of SAQ,frequency of ST depression and time of ST depression compared to treatment before(all P＜0.05).the effect of comprehensive intervention was the same as drug therapy.
Conclusions:
①we investigated conditions of aging coronary artery disease patients with depression in changsha for the first time.The results indicated that the prevalence of depression in aging patients with coronary heart disease was high.The prevalence of female patients was higherthan that of male patients.Female,aging,lower degree of culture, non-ambulatory and lower social support were correlation with depressive status.
②For the first time we found that interleukin-17 and C-reactive protein may play an important role in the mechanism of aging coronary heart diseasewith depression.
③Comprehensive intervention can lighten depressive systoms, elevate quality of life and improve symptoms of angina
Chapter 1 Analysis of relationship between depressive
status and psychosocial factors in aging coronary heart
disease
Objective:
To explore the risk factors and morbility of depression in aging patients with coronary heart disease(CHD)。
Methods:
A cross-sectional study was conducted in communities of wang yuehu,Chenjiahu and Guangjiqiao in changsha from June in 2006 to Feburary in 2008.332 CHD patients were selected randomly.Face to face interview was used in data collection together with the HAMD,social support rating scales and investigate scales self-made.Multinomial Logistic Model was adopted in date analysis.
Results:
①Among 332 patients,152 patients suffered from depression (45.8%).115 patients(34.6%) were minor to middle depressive disorders and 37 patients(11.2%) were major depression.
②The prevalence,of depressive status in 70-year group was higher than that of 60-year group(55.8%VS 36.9%,P＜0.05).
③The prevalence of depressive status in female aging patients was higher than that of male aging patients(48.9%VS 43.2%,P＜0.05).
④Female,age,lower culture degree and non-ambulatory patients had a statistically higher risk of depression with the OR at 1.48,1.69, 2.154,8.92,(all P＜0.05)
⑤Subjective support scores and utilized degree to support scores of depressive stares groups were all higher than that of non-depressive status groups(15.0±3.9 VS 22.6±4.0,6.4±2.0 VS 8.0±2.0,respectively,all P＜0.05).
⑥Objective support scores,subjective support scores and utilized degree to support scores were not correlation with HAMD scores.
Conclusion:
It was noticeable that the prevalence of depressive status in patients of aging coronary heart disease was high.With aging increasing,the prevalence increased,The prevalence of depressive status in female patients were higher than that of men patients.Low culture level, non-ambulatory patients and low social support were associated with depressive status.
Chapter 2 Changes of interleukin-17 and C-reactive protein
in aging coronary heart disease patients with depressive
status
Objective:
The aim was to evaluate levels of IL-17 and CRP in plasma of aging coronary heart disease patients with depressive status and expression of IL-17 in monocytes of these patients.
Methods:
We analyzed the concentrations of IL-17 and CRP in plasma using enzym-linked immunosorbent assay and expression of IL-17 in monocytes using RT-PCR in 68 selected patient randomly divided into two groups,depressive status group(n＝38)and un-depressive status group(n＝30).
Results:
①Concentrations of IL-17 and CRP were significantly higher in aging depressive status patient with coronary heart disease than those of the control group(323.96±97.15 pg/ml VS 214.30±58.08 pg/ml,4.86±1.32 ng/ml VS 2.16±0.69ng/ml,all P＜0.01).Expression of IL-17 in monocytes of aging depressive status with coronary heart disease were higher than that of the control group(0.55±0.14,0.26±0.08,P＜0.01).
②In aging coronary heart disease patients with depressive status group,levels of IL-17 and CRP and expressions of IL-17 in monocytes in acute coronary syndrome accompanied depressive status group were higher than those of stable angina accompanied depressive status group. (372.67±91.39 pg/ml VS 284.57±84.45 pg/ml,5.51±1.36ng/ml VS 4.28±1.01 ng/ml,0.62±0.19 VS 0.49±0.13,all P＜0.01)
③In aging coronary heart disease patients depressive status group concentrations of IL-17 major depressive status patients were significantly higher than those of minor to moderate depressive status patients(395.42±128.75pg/ml,310.27±96.35pg/ml p＜0.01).The plasma levels of CRP in aging coronary heart disease patients with major depression status were increased as compared,with minor to moderate depressive status patients(4.90±1.38ng/ml,4.10±1.25ng/ml,P＜0.01). Expression of IL-17 in monocyte of aging coronary heart disease with major depressive status were elevated as compared with minor to moderate depressive status patients(0.61±0.22,0.48±0.13, P＜0.01).Expression of IL-17 in the major depression patients were higher than that of the minor to moderate depression patients,(P＜0.05).
④The prevalence of major depressive status in acute coronary syndrome was higher than that in stable angina in aging coronary heart disease patients with depressive status(P＜0.05).
⑤The levels of CRP were positively related with IL-17 in aging coronary heart disease patients with depressive status (r＝0.802,P＜0.05).The concentration of IL-17 and CRP were positively associated with the scores of HAMD(r＝0.672,P＜0.05,r＝0.421,P＜0.05).
Conclusion:
Interleukin-17 and C-reactive protein are play an important role in the mechanism of aging coronary heart disease with depressive status.
Chapter 3 The effect of comprehensive intervention on
quality of life of aging coronary heart disease patients
with depressive status
Objective:
To study whether comprehensive intervention for depression in aging patients with coronary heart disease(CHD) can or not lead to some improvement in depressive symptoms,quality of life and ischemia of myocardium.
Methods:
96 depressive status aging patients with coronary heart disease were alloted into comprehensive intervention group(n＝50),drug treatment group(n＝46)randomly.Patients received comprehensive intervention and anti-depressant serotonin HCIz(zoloft,Pfizer50mg qd) on the basis of conventional cardiac medicine therapy for 12 weeks in the comprehensive intervention group and drug therapy,respectively.
Results:
①After treatment scores of HAMD and SAQ and change of ST were improvement in comprehensive intervention group and drug treatment group.Scores of HAMD were lower than treatment before(17.85±5.38 VS 28.72±7.54,18.72±6.17 VS 27.85±8.27,respectively,all P＜0.01)in the two groups.Scores of activate restriction were higher than treatment before(32.32±8.67 VS 26.58±5.30,33.28±7.95 VS 27.32±5.47,all P＜0.01)in the two groups,Scores of contest degree were higher than treatment before(16.39±4.83 VS 14.20±2.64,16.31±5.07 VS 13.98±4.02,all P＜0.01)in the two groups.Total scores of SAQ were higher than treatment before(80.25±25.32 VS 62.19±12.35,83.27±27.12 VS 63.07±13.54,all P＜0.01),Score of angina attack were higher than treatment before(8.19±2.45 VS 7.05±2.35,8.06±2.63 VS 6.97±2.18,all P＜0.05).Frequency of ST depression were lower than treatment before(32.5±12.7 VS 84.3±13.8, 31.9±13.9 VS 82.2±15.7,all P＜0.05).Times of ST depression were lower than treatment before(88.4±28.7 VS 172.5±32.8,89.5±32.7 VS 176.3±36.4,all P＜0.01).There were no difference in the scores of angina stability between treatment before and.after treatment in two. group(3.52±0.87 VS 3.02±1.27,3.47±0.95 VS 2.95±1.15,all P＞0.05).
②There were no difference in scores difference of HAMD among the two groups after treatment(9.03±3.15,9.35±3.01,P＞0.05).There were no difference in scores difference of degree to recognizing disease,activate restriction,angina attack,content degree,angina stability and total SAQ among the two groups(2.32±0.67 VS 2.28±0.65,6.32±1.81 VS 6.10±2.05,1.17±0.38 VS 1.08±0.29,2.13±0.68 VS 2.09±0.63,0.52±0.17 VS 0.49±0.16,19.98±6.56 VS 19.75±6.72 respectively,all P＞0.05).There were no difference in difference of frequency and times of ST depression among the two groups(50.08±16.75 VS 50.75±17.36, 92.75±31.26 VS 88.75±30.92,respectively,all P＞0.05).
Conclusion:
Comprehensive intervention can relieve depressive symptoms,improve quality of life and improve anginal symptoms.
引文
[1]National Heart,Lung and Blood Institue.Morbidity and mortality:1998chartbook on cardiovascular,Lung,and blood disease,Rockville:US Department of health and Human Services,National Iustitute of Health;1998.
[2]吴兆苏,姚崇华,赵冬等.我国多省市心血管疾病趋势及决定因素的人群监测(中国MONICA方案):发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11.
[3]吴贵贤,吴兆苏,刘军等.北京部分地区15年心脑血管病死亡率变化趋势[J].中华预防医学杂志,2001,35(2):98-101.
[4]Rozanski A,Blumenthal JA,Kaplan J.Impact of psychological factor on the pathogenesis of cardiovascular disease and implications for therapy.Circulation,1999;99:2191-2217.
[5]Melle JP,de Jonge P.Spijkerman TA,et al.Prognostic association of depression following myocardial infarction with mortality and cardiovascular events:a meta-analysis.Psychosom Med 2004;66:814-822.
[6]Blumenthal JA,Lett HS.Babyak MA,et al.Depression as a risk factor for mortality after coronary artery bypass surgery.Lancet 2003;362:604-609.
[7]Lesperance F,Frasmre-Smith N,Talapic M,et al.Five-year risk of cardiac mortality in relation to inital severity and one-year changes in depression symtoms after myocardial infarction.Circalation 2002;105:1049-1053.
[8]Rugulies R.Depression as a predictor for coronary:a review and meta-analysis.Am J Pre Med 2002;23:51-61
[9]Wulsin LR,Singal BM.Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.Psychosom Med 2003;65:201-10.
[10]杜秀丽,姜亚芳,杨宏梅等.住院冠心病患者抑郁情绪及相关因素的调查分析[J].中华护理杂志,2003,10(38):731-764.
[11]张明圆.精神科评定量表手册[M].长沙:湖南科学技术出版社,2004,121-126.
[12]肖水源.《社会支持评定量表》的理论及临床应用[J].临床精神医学杂志,1994,4(2):98-100.
[13]王金荣,王德平,沈温等.中国七个地区情感性精神障碍的流行病学调查[J].中华精神科杂志,1998,31(2):75-77.
[14]周英,尤黎明.冠心病人心理健康状况调查及护理[J].中华护理杂志,2003,38(11):836-838.
[15]任显峰,白慧丽,郑素娟.冠心病患者的情绪障碍和述情障碍[J].健康心理学杂志,2003,11(3):231-232.
[16]古丽松、林艳、本妮拉.冠心病患者的情绪问题和临床意义[J].心血管康复医学杂志,2002,11(3):220-221.
[17]尤雪莲,任俊翠,袁秀银等.住院病人焦虑抑郁状况及影响因素调查[J].临床护理杂志,2004,3(2):7-9.
[18]Arthur HM,Swabey T,Sukin N,Ross J.The Onrtario cardiac Rehabititation Pilot Project:recommendations for health planning and policy.Can J Cardid 2002;20(12):1251-1255.
[19]Todaro J,shen B,Niaura R,er al.Prevalence of depression disorders in men and women enrolled in cardiac rehabilitation.J Cardiopulm Rehabil 2005;25(2):71-75.
[20]Davis JC,Jackson PR,Potokar J,et al,Treatment of anxiety and depressive disorders in patient s with cardiovascular disease.BMJ 2004;328:39-43.
[21]陈银娣,周天骍,施慎逊等.老年冠心病病人焦虑、抑郁症状的调查[J].上海精神医学,2000,12(1):17-18.
[22]雍生满、周保、栾红等.住院冠心病人焦虑抑郁病状的调查[J].宁夏医学杂志,2006,28(8):66-607.
[23]付朝伟、徐飚、栾红等.大城市综合医院冠心病抑郁/焦虑影响因素探讨[J].卫生研究,2006,35(5):634-636.
[24]闫芳、李淑然.老年期痴呆和老年抑郁症的流行病学调查[J].中华医学杂志,2002,15(82):1025-1028.
[25]周成刚、任寰、曾火飚等.农村社区冠心病并发抑郁发生率和相关因素的研 究[J]. 现代预防医学, 2006; 36 (6): 877.
[26]Davidson PM, Daly J, Hancock k, et al, Perception and experience of heart disease: a Literature review and identification of a research agenda in older women. Eur J Cardiovas Nurs 2003;2(4):255-264.
[27]Frasure-Smith N, Lesperance F, Talajic M,et al. Gender, depression, and one-year prognosis after myoardial infarction. Psychosom Med 1999;61:26-37.
[28]Arthur HM, Swabey T. Suskin N, et al. The Ontario Cardiac Rehabilitation Pilot Projectirecommendations for health Planning and policy. Can J. Cardiol 2002;20(12):1251-1255.
[29]Ferketicah AK, Schwartx baum JA, Frid DJ, et al. Depression as an Antecedent to Heart Disease Among Women and men and men in the NHANESI Study. Arch Int Med 2000;160(P):1261-1268.
[30]Von Hout HP, Beekman AT, De Beurs E, et al. Anxiety and the risk of death in older men and women, Br Psychiatry 2004;185:399-404.
[31]Deng L, Luan RS, Luo XH, et al. Population surveillance on psychosocial factors and overall health. Zhong guo Gonggong Weisheng 2003;19(l):115-7
[32]Cheng WH, chen s, Tang HQ, et al. School avoidence and psychological defense style of students at senior high shool. Shanghai Jingshen yixue 2003;15(2):80-82.
[33]Berkman LF, Leo-Summes L , Horwitz RI, et al. Emotional support and survial after myocardial infarction:a prospective, population-based study of the elderly.Ann Intern Med 1992; 117:1003-100.
[34]Williams RB, Barefoot TC, Califf RM. et al. prognostic importance of social and economic resource amonry medically treated patients with angiographrically documented coronary artery disease JAMA 1992;267:520-524.
[35]Brummett BH, Babyak MA, Barefoot JC, et al. Social support and hostility as predictors of depression symptoms in cardiac patients one month following hospitalization:a prospective study. Psychosom Med 1998;60:707-713.
[36]Brummett BH, Babyak MA, siegler IC, et al. Relation of subjective and received social support to clinical and self-report assessments of depressive symptoms in an elderly population. J affect Disord 2000;61:41-50.
[37]Oxmall TE.Huil JG..Social support,depression,and activities of daily living in older heart surgery patients.J Gerontol B Psychol sci sa sci 1997;52:1-14.
[38]张迎黎、李鹤展.社会支持与抑郁症病的相关分析[J].中国临床康复,2003,7:4108-4109。
[39]Wildes JE,Harkness KL,Simons AD.Life events,number of social realtionships,and twelve-month naturalistic course of major depression in a community samples of women.Depress Anxiety 2002;16(3):104-13.
[40]Asto c,Navarro V,Catalan R,et al.Residual symptoms in elderly major depression remitters.Acta Psychiatr Scand 2003;108(1):15-19
[1]Ross R.Atherosclerosis—an inflammatory disease.N Engl J Med 1999;340:115-126.
[2]Vorchheimer DA,Fuster V.Inflammatory marke in coronary artery disense,let prevention douse the tlames.JAMA 2001;289:2154-2156
[3]Brueckmann M,Rretsch T,Langs,et al.Time course of systemic marders of inflammation in patients presenting with acute coronary syndromes.Clin chem Lab Med 2004;42:1132-1139
[4]Miller GE,Cinnamon A,Steler RM,etal.Clinical depression and inflammatory risk markers for coronary heart disease.Am J Cardiol 2002,po:1279-1283.
[5]Edward CS,C-reactive protein is associated with psychological risk factor of cardiovascular disease in apparently health adults.Psychosom Med 2004,66:684-691
[6]Thomas AJ,Ferrier IN,Kalarin RN,et al.Cell adhesion molecule expression in the dorsolarel prefrontal cortex and anterior cingulate cortex in major depression in the elderly.Br J Psychiatry 2002;181:129-134.
[7]Dentino AN,Pieper CF,Rao KMK,et al.Association of interleukin-6 and other biological variables with depression in older people living in the community.J Am Geriatr Soc 1999;47:6-11.
[8]Fossiez F,Djossou o,chomarat P,et al.T-cell interlenkin17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.J Exp Med 1996;183:2593-2603.
[9]Aggarwal s,Ghilardi N,Xie MH,et al.Interleukin-23 promotes a distinct CD4T-cell activation state charactize by the production of interleukin-17.J Biol Chem 2003;278:1910-1914.
[10]Moseley TA,Handenschild DR,Rose L,et al.Interleukin-17 family and IL-17receptor.Cytokin Growth Factor Rev 2003;14:155-174 Survey.
[11]Empana JP,Sykes DH,Luc G,et al.Contribution of depressive mood and circulation inflammatory markers to coronaRy heart disease in healthy European men.The prospective epidemiologicd study of myocardial infarction(PRIME).Circulation,2005;111-2299-2305
[12]Hashimi S,Zeng QT.Role of interleukin-17 and interleukin-17-induced cytokines inerleukin and interleukin-8 in unstable coronary artery disease.Coronary artery disease 2006;17(8):699-706.
[13]张明园.精神科评定量表手册.长沙:湖南科学技术出版社,1993:16-222.
39.Raynes J,Eagling S,Mcadam K,Acute-phas protein synthesis in human hepatoma cell:differential regulation of serum amytoid A(SSA)and heptoglobin by Interleukin-1 and interleukin-6.Clin Exp Imunol,1999;83:488-91.
[14]Kidker PM,Rifai N,stamper MJ et al.Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.Circulation 2000:101:1767-72.
[15]Rider PM,Hennekens CH,Buring JE,Rifai N,C-reactive protein and other markers of inflammtion in the prediction of cardiovascular disease in women,N Engl J med 2000;342:836-43.
[16]Blankenberg S,Tiret L.Bickel C,et al,Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.Circulation 2002;106:24-30.
[17]Panagiotakos DB,Pitsavos C,Chrysohoou C,et al.Inflammation,coagulation and depressive symtomatoloy in cardiovasuder disease-free people;the ATTICA study.Eur Heart J.2004;25:492-9.
[18]Suarez EC,lewis JG,Krishnan RR,et al,Enhanced expression of cytokines and chemokines by blood momocytes to in vitro lipoplysaccharide stimulation are associated with hostility and severity of depressive systoms in healthy women.Psychoneuroendocrinology 2004;29:119-28.
[19]Miller GE,Steler CA,Carney RM,Freedland KE,et al.Clinical depression and inflammatory risk markers for coronary heart disease.Am J Cardiol 2002;90:1279-83.
[20]Kop WJ ,Gottdiener JS ,Tangen-CM,et al.Inflammation and coagulation factors in persons >65years of age with symtoms of depression but without evidence of myocardial ischemia Am J cardiol 2002;89:419-24.
[21]Appels A,Bar FW,Bar J,et al.Infiammation,depressive symptomatology,and coronary artery disease.Psychosom Med 2000;62:601-5.
[22]Lesperance F,Frasure-smith N,Therous P,et al.The association between major depression and levels of soluble intercellular adhesion molecule l.interleukin,and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161:271-7.
[23]Kostulas NBS, Plidon H, Kivisakk P, et al.Increased IL-l[beta] 、 IL-8,IL-17mRNA expression in blood mononucler cells observed in a prospective ischemic stroke study. Stroke 30(10):2174-2179.
[24]Yao,z Fanslow WC,seldin MF,et al.Herpsvirus saimiri encodes a new cytokin,IL-17,which binds to a .novel cytokine receptor. Immumity 1995;3(6):811-821.
[25]Fossiez F,Djossou O,Chomarat P,et al.T cell interleukin-17 induces stromal cell to produce proinflammatory and hematopoietic cytokines.J Exp Med 1996.183(6):593-603.
[26]Moseley TA, Haudenschil OR, Rose L, et al. Interleukin-17 family and IL-17 receptors. Cytokin Growth Factor Rev 2003;14:155-174.
[27]Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated c-reative protein, Psychosom Med 2003; 65:347-356.
[28]Schins A, Tulner D, Lousberg R, et al. Inflammatory markes in depressedl post-myocardial infarction patients. J Psychiatr Res 2005;39:137-144.
[29]Michon IN, Devos P,Van Berkel T,et al. The role of IL-17 in atherosclerotic lesion formation in mice xⅢth Internation symposium on Atherosclerosis.28 september-2 October 2003 .Kyoto Japan.
[30]Michon IN,Devos P,Van wanrooij E,et al,Activation of Macrophages by IL-15 and IL-17 in atherosclerotic lesion development. ICI/FOCIS 2004.
[31]Aggarwal S,Gurney AL.IL-17:protoype member of an emerging cytokine family.J LeukinBiol 2002;71:1-8.
[32]Hata K.Andoh A,shimada M,et al.IL-17 stimulates inflammatory response via NF-[Kappa] B and MAP Kinase pathways in human colonic myofibroblasts. Am J physio Gartrointest Liver physiol 2002;282:G1035-1044.
[33]Kotake S,Udagawa N,Takahashi N,et al,IL-17 in synovial fluids from patients with rheumatoid athritis is a potent stimulator of osteoclastogenesis,J Clin Invest 1999;103:1345-1352.
[34]Falk E.Coronary thrombosis:Pathogenesis and clinical manifestations. Am J cardiol 1991;68;B28-35.
[35]Libby P Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
[36]Davies MJ.stability and instability:two faces of coronary atherosclerosis; Panl Dudley white Lecture 1995:Circulationl996;94:2013-2020.
[37]Lesperance F,Fracnre-Smith N,Theroux P,et al.The association between major depression and Levels of solube intercellalcar adhesion molecule 1 .interleukn-6 and C-reactive protein in patients with recent acute coronary syndrome .Am J Psychiatry 2004;161:271-7.
[38] Suarez EC, Lewis JG, Krishnan RR, et al. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and servity of depressive systoms in healthy women.Psycho neurendocrinology 2004;29:119-28.
[39]Smith JW, MeDonald TL. Production of serum amyloid A and c-reactive protein by Hepg2 cell stimulated with combination of cytokin of monocyte conditioned media:the effect of prednisone.Clin Exp Immunol 1992;90:293-299.
[1]杨菊贤.心理行为因素与心血管病变的发生发展[J].心血管病学进展,2001,22:295-297.
[2]黄佐,樊民,吴宗贵.冠心病患者抑郁症状与冠状动脉病变的关系[J].中国临床康复,2005,9(4):46-47.
[3]管绯,周红萍,何昆露.心理评估与健康教育对抑郁症老年冠心病患者近期预后的影响[J].中国实用医药,2007;9(2):25-27.
[4]张颖,张爱伦.老年抑郁症与冠心病[J].新疆医科大学学报,2006;29(4):371-373.
[5]Giltay EJ,Geleijnse JM,Dispositional optimison and all-case and cardiovascular mortality in a prospective cohort of elderly Dutch men and women.Original Article 2004,61(11):1126-1135.
[6]付朝伟,徐飚,栾荣生等.大城市综合医院冠心病人抑郁/焦虑影响因素探讨[J].卫生研究,2006,35(5):634-636.
[7]张亚哲,赵耕源,张书刚等.心理干预在冠心病治疗中的作用[J].中国行为医学科学,1997,6(1):39-41.
[8]李文学,张文新,付绪杰.冠心病患者伴抑郁行为心理治疗对其心绞痛和心电图的影响[J].实用药杂志,2004;21(12):1065-1607.
[9]张明圆.精神科评定量表手册[M].长沙:湖南省科学技术出版社,1993:16-222.
[10]饶中和,彭志敏.一种新的估测冠心病患者机体功能状态的调查表[J].国外医学,老年医学分册,1996;17(1):14-16.
[11]马魏,藤雅轩.认知心理干预对心绞痛患者负情情绪及心肌缺血程度的影响[J].中国临床康复,2005;9(24):25-27.
[12]Gorman JM,Sloan RP.Heart rate variability in depressive and anexity disorders.An Heart J 2000;140(4 suppl):77-83.
[13]侯云英,范秀珍.冠心病患者抑郁情绪与生活质量的相关研究[J].解放军护理杂志,2006,23(7):4-13.
[14]Feubstein RE,Blumenfield M,Orlowski B,et al.A national survey of cardiovascular physician beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.Cardiol Rev 2006;14(4):164-169
[15]Writing committee for the ENRICHD investigators.Effects of treating depression and low social support on clinical events after myocardial infarction:The enhancing recovery in coronary heart disease patients(ENRICHD) randomized trial.JAMA 2003,289:3106-16.
[16]李冬梅,心理干预对改善老年冠心病抑郁状况的临床研究[J].现代医药卫生,2006:22(9):1283-1284
[17]姚云,常丽,陈君风.心理干预对冠心病患者伴焦虑抑郁症状疗效评估[J].临床心身疾病杂志,2007;13(5):437-438.
[18]Penninx BW,Beekman ATF,Honig A,et al Depression and cardiac mortality:results from a community-based longitudinal study.Arch Gen Psychiatry 2001,58(3):221-227.
[19]许燕,张建欣.冠心病患者焦虑抑郁的心理护理[J].解放军护理杂志,2008,25(1A):32-33.
[19]Loucks EB,Berkman LF,Gruenewald TL,et al.Relation of social integration to inflammatory marker concentrations in men and women 70 tO 79 years.Am J cardiol 2006;97(7):1010-6.
[20]Abraham AA,Mary H,Caherine MT,et al.Depression systoms and risk of coronary heart disease and mortality in elderly Americans.Circulation 2000;102:1773-9.
[20]Blumenthal JA,Babyak M,Wei J,et al.Usefulness of psychosociat treatment of mental stress-induced myocardial ischemia in men.Am J Cardiol 2002;89:164-8.
[1]Kop WJ,Ader DN.Assessment and treatment of depression in coronary artery disease patients.Ital Heart J 2001;2(12):890-4...
[2]Schleifer SJ,Macari-Hinson MM,Coyle DA,et al.The nature and course of depression following myocardial infarction.Ach Intern Med 1989;149:1785-9
[3]Thornton LA.depression in post-acuate myocardial infarction patients.J Am Acad Nurse Pract 2001;13(8):364-7
[4]黄佐,樊民,吴宗贵。冠心病患者抑郁与冠状动脉病变的关系,中华心血管 病杂志,2003;31(5):329
[5]雍生满,周保,栾红等。住院冠心病人焦虑抑郁症状的调查,宁夏医学杂志,2006:28(8):606-607
[6]Roseyren A,Hawken S,ounpuu S,et al.Effect of psychosocial risk factors with risk of acute myocardial infarction in 1119 cases and 13468 controt fron 52 co untries C the INTERHEART study):case-control study[J].Lancet,2004,364:953-P62.
[7].Abraham AA,Mary H,Catherine MT,et al.Depression systoms and risk of coronary heart disease and mortality in elderly Americans.Circulation.2000;102:1773-9
[8]Barefoot JC,Helm S Mark DB,et al.Depression and long-term mortality risk in patients with coronary artery disease.Am J Cardiol 1996;78(6):613-7
[9]O'Mally PG;JonesDI,Feuentein IM et al.Lake of correlation between psychological factors and subclinical coronary artery disease.Am J Heart.2000;86:1135-8
[10]吴京兰,苏又苏,付剑云等。老年冠心病患者抑郁程度与心肌缺血的关系,中国康复理论与实践,2005;11(1):51-52
[11]周成刚,任寰,曾火飚等。农村社区冠心病并发抑郁发生率和相关因素的研究,现代预防医学,2006;36(6):877
[12]Lesperance F,Frasure-Smith N,Theroux P,et al.The association betweem major depressiom and levels of selubte cellutlar adhesion moleculei,interleukin-6,and c-reactive protein in prtients with recent acute coronary syndromes.Am J p sychiatry,2004,161:271-277
[13]Miller GE,Freedland KE,Duntley S,at el.Relation of depressioe symptoms to c-reuctive protein and pathoyen burden c cytomegalovirus,herpes wimplex virus Dpstein-Barr virus)in patients with earlier acute coronary syndromes.Am J cardiot,2005.95:317-321
[14]Schis A,Tulner D,Lousberg R,et al.Infcammatory markers in depressed post-myocardial infarction patients.J Psychiatrn,Res,2005,39:137-144
[15]Miler GE,Stetler CA,Carney RM,et al.Clinical depression and inflammatory risk markers for coronary heart disease.AM J Cardiol,2002,90:1279-1283
[16]Pender R,Pories WJ,Epidemiology of obesity in the Unite States.Gastroenterol Clin North Am:2005,34(1):1-7
[17]Lee RS,Kim YH,Beck BH,et al.Depression mood and abdominal fat distribution in overweight preneopasual women.Obes Res,2005;13(2):320-325
[18]Wellen KE,Hotanisligil GS.Inflammation,stress and diabetes.J Clin Invest,2005;115(5):1111-1119
[19]Hjerkinn EM,Seljeflkt I,Ellingsen I,et al,Intluence of long-term interventim with dietary counseling,ling-chinn-3 fatty acid supple ments,or both on cirulation markers of endothelial activation in men with ling-standing typerlipidemia,Sm F Clin Nutr,2005,81:583-589.
[20]Vigo DE,Nicola Sift L,Ladron De Guevara MS et al.Relation of depression to heart rate nonlinear dynamics in patients≥60 years of age with recent unstable angina pectoris or acuate myocardial infarction patients.Am J Cardiol,2004;93:756-760
[21]Drago S,Berggrone S,Anselmino M,et al,Depression in patients with acute myocardial infarction:Influence on autonomic mervous system and prognostic role:Results of a five year follow up study.Int J Cardiol,2007,115(1):46-51
[22]Vonkannel R.Platelet hyperactivity in clinincal depression and the beneficial dffect of antidepressiont druy treatment:How strong is the evidenc.Acta pcychiatr scand,2004,110:163-177.
23.Sherwood A,Hinderliter AL,watkins LL,et al.Impaired endothelial function in coronary teart disease patieuts with depressive symptomology,J Am cardial.2005,46:656-659.
25.Mccaffery JM,Fracur-smith N,Dube MP,et al,commom genetic vulneralility to depressive symptoms and coronary artery disease.A review and development of candidate genes related to intlammaiton and sterotinin psychosom Med,2006,68:187-200.
[26]Nakatani D,Sato H,sarata R,et al,influence of serotomin transporter gene polymorphism on depressive xymptoms and new cardioc events after acute myocardial infarction,Am Heart J 2005,150:652-658.
[27]付朝伟,徐飚,栾荣生等。大城市综合医院冠心病人抑郁/焦虑影响因素探讨, 卫生研究,2006;35(5):634-636
[28]徐为民,冯丽。冠心病与感染和抑郁的关系,中国社区医师,2004;20(18):35
[29]Loucks EB,Berkman LF,Gruenewald TL,et al,Relation of social integration to inflammatory marker concentrations in men andwomen 70 to 79 years.Am J Cardiol.2006;97(7):1010-6.Epub 2006 Feb 20.
[1] Jiang W, Glassman A, Krishnan R, et al. Depression and ischemic heart disease: what have we learned so far and what must we do in the future? Am Heart J 2005; 150:54-78.
[2] Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217.
[3] Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality:results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
[4] Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158:1422-6.
[5] Stansfeld S, Fuhrer R. Depression and coronary heart disease. In: Stansfeld S,Marmot M, eds. Stress and the heart. London: BMJ Books, 2002:101-23.
[6] Stansfeld SA, Fuhrer R, Shipley MJ, et al. Psychological distress as a risk factor for coronary heart disease in the Whitehall Ⅱ study. Int J Epidemiol 2002;31:248-55.
[7]Empana JP, Jouven X, Lemaitre RN, et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med 2006; 166:195-200.
[8]Shimbo D, Davidson KW, Hass DC, et al. Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, future directions. J Thromb Haemost 2005; 3:897-908.
[9]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
[10].Naghavi M, Libby P, Falk E,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72.
[11]Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
[12]Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease:is there a link? Lancet 1997;350:430-6.
[13]Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
[14]Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
[15]Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study.Circulation 1997;96:4219-25.
[16]Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
[17]Ozeren A, Aydin M, Tokac M, et al. Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators Inflamm 2003;12:361-5.
[18]Fang L, Wei H, Mak KH,et al. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease. Can J Cardiol 2004;20:1433-8.
[19]Hajilooi M, Sanati A, Ahmadieh A, Ghofraniha A, Massoud A. Circulating ICAM-1, VCAM-1, E-selectin, P-selectin, and TNFRⅡ in patients with coronary artery disease. Immunol Invest 2004;33:263-75.
[20]Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk.Int J Clin Pract Suppl 2003;10-7.
[21]Lindmark E, Diderholm E, Wallentin L, et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13.
[22]Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
[23]Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002;39:1133-8.
[24]Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.
[25].Miller GE, Stetler CA, Carney RM, et al. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83
[26].Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56
[27]Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression and CRP in patients with recent acute coronary syndromes. In Preparation.
[28]Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression, sICAM-1, interleukin-6 and CRP in patients with recent acute coronary syndromes. Am J Psychiatry; in Press.
[29]Rajagopalan S, Brook R, Rubenfire M, et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196.
[30]Bluthe RM, Laye S, Michaud B,et al. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: A study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 2000;12:4447-56.
[31]Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999;61:476-87.
[32]Kop WJ, Cohen N. Psychological risk factors and immune system involvement in cardiovascular disease. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001:525-44.
[33]Kop WJ, Ader DN. Assessment and treatment of depression in coronary artery disease patients. Ital Heart J 2001;2:890-4.
[34]Kop WJ, Appels A, Mendes de Leon CF, et al. The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res 1996;40:397-405.
[35]Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
[36]Goodkin K, Appels A. Behavioral-neuroendocrine-immunologic interactions in myocardial infarction. Med Hypotheses 1997;48:209-14.
[37]Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
[38]Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 1989;44:1995-2008.
[39]Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 2005;29:891-909.
[40]Capuron L, Ravaud A, Miller AH, Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun2004;18:205-13.
[41]Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S,Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-6.
[2]吴兆苏,姚崇华,赵冬等.我国多省市心血管疾病趋势及决定因素的人群监测(中国MONICA方案):发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11.
[3]吴贵贤,吴兆苏,刘军等.北京部分地区15年心脑血管病死亡率变化趋势[J].中华预防医学杂志,2001,35(2):98-101.
[4]Rozanski A,Blumenthal JA,Kaplan J.Impact of psychological factor on the pathogenesis of cardiovascular disease and implications for therapy.Circulation,1999;99:2191-2217.
[5]Melle JP,de Jonge P.Spijkerman TA,et al.Prognostic association of depression following myocardial infarction with mortality and cardiovascular events:a meta-analysis.Psychosom Med 2004;66:814-822.
[6]Blumenthal JA,Lett HS.Babyak MA,et al.Depression as a risk factor for mortality after coronary artery bypass surgery.Lancet 2003;362:604-609.
[7]Lesperance F,Frasmre-Smith N,Talapic M,et al.Five-year risk of cardiac mortality in relation to inital severity and one-year changes in depression symtoms after myocardial infarction.Circalation 2002;105:1049-1053.
[8]Rugulies R.Depression as a predictor for coronary:a review and meta-analysis.Am J Pre Med 2002;23:51-61
[9]Wulsin LR,Singal BM.Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.Psychosom Med 2003;65:201-10.
[10]杜秀丽,姜亚芳,杨宏梅等.住院冠心病患者抑郁情绪及相关因素的调查分析[J].中华护理杂志,2003,10(38):731-764.
[11]张明圆.精神科评定量表手册[M].长沙:湖南科学技术出版社,2004,121-126.
[12]肖水源.《社会支持评定量表》的理论及临床应用[J].临床精神医学杂志,1994,4(2):98-100.
[13]王金荣,王德平,沈温等.中国七个地区情感性精神障碍的流行病学调查[J].中华精神科杂志,1998,31(2):75-77.
[14]周英,尤黎明.冠心病人心理健康状况调查及护理[J].中华护理杂志,2003,38(11):836-838.
[15]任显峰,白慧丽,郑素娟.冠心病患者的情绪障碍和述情障碍[J].健康心理学杂志,2003,11(3):231-232.
[16]古丽松、林艳、本妮拉.冠心病患者的情绪问题和临床意义[J].心血管康复医学杂志,2002,11(3):220-221.
[17]尤雪莲,任俊翠,袁秀银等.住院病人焦虑抑郁状况及影响因素调查[J].临床护理杂志,2004,3(2):7-9.
[18]Arthur HM,Swabey T,Sukin N,Ross J.The Onrtario cardiac Rehabititation Pilot Project:recommendations for health planning and policy.Can J Cardid 2002;20(12):1251-1255.
[19]Todaro J,shen B,Niaura R,er al.Prevalence of depression disorders in men and women enrolled in cardiac rehabilitation.J Cardiopulm Rehabil 2005;25(2):71-75.
[20]Davis JC,Jackson PR,Potokar J,et al,Treatment of anxiety and depressive disorders in patient s with cardiovascular disease.BMJ 2004;328:39-43.
[21]陈银娣,周天骍,施慎逊等.老年冠心病病人焦虑、抑郁症状的调查[J].上海精神医学,2000,12(1):17-18.
[22]雍生满、周保、栾红等.住院冠心病人焦虑抑郁病状的调查[J].宁夏医学杂志,2006,28(8):66-607.
[23]付朝伟、徐飚、栾红等.大城市综合医院冠心病抑郁/焦虑影响因素探讨[J].卫生研究,2006,35(5):634-636.
[24]闫芳、李淑然.老年期痴呆和老年抑郁症的流行病学调查[J].中华医学杂志,2002,15(82):1025-1028.
[25]周成刚、任寰、曾火飚等.农村社区冠心病并发抑郁发生率和相关因素的研 究[J]. 现代预防医学, 2006; 36 (6): 877.
[26]Davidson PM, Daly J, Hancock k, et al, Perception and experience of heart disease: a Literature review and identification of a research agenda in older women. Eur J Cardiovas Nurs 2003;2(4):255-264.
[27]Frasure-Smith N, Lesperance F, Talajic M,et al. Gender, depression, and one-year prognosis after myoardial infarction. Psychosom Med 1999;61:26-37.
[28]Arthur HM, Swabey T. Suskin N, et al. The Ontario Cardiac Rehabilitation Pilot Projectirecommendations for health Planning and policy. Can J. Cardiol 2002;20(12):1251-1255.
[29]Ferketicah AK, Schwartx baum JA, Frid DJ, et al. Depression as an Antecedent to Heart Disease Among Women and men and men in the NHANESI Study. Arch Int Med 2000;160(P):1261-1268.
[30]Von Hout HP, Beekman AT, De Beurs E, et al. Anxiety and the risk of death in older men and women, Br Psychiatry 2004;185:399-404.
[31]Deng L, Luan RS, Luo XH, et al. Population surveillance on psychosocial factors and overall health. Zhong guo Gonggong Weisheng 2003;19(l):115-7
[32]Cheng WH, chen s, Tang HQ, et al. School avoidence and psychological defense style of students at senior high shool. Shanghai Jingshen yixue 2003;15(2):80-82.
[33]Berkman LF, Leo-Summes L , Horwitz RI, et al. Emotional support and survial after myocardial infarction:a prospective, population-based study of the elderly.Ann Intern Med 1992; 117:1003-100.
[34]Williams RB, Barefoot TC, Califf RM. et al. prognostic importance of social and economic resource amonry medically treated patients with angiographrically documented coronary artery disease JAMA 1992;267:520-524.
[35]Brummett BH, Babyak MA, Barefoot JC, et al. Social support and hostility as predictors of depression symptoms in cardiac patients one month following hospitalization:a prospective study. Psychosom Med 1998;60:707-713.
[36]Brummett BH, Babyak MA, siegler IC, et al. Relation of subjective and received social support to clinical and self-report assessments of depressive symptoms in an elderly population. J affect Disord 2000;61:41-50.
[37]Oxmall TE.Huil JG..Social support,depression,and activities of daily living in older heart surgery patients.J Gerontol B Psychol sci sa sci 1997;52:1-14.
[38]张迎黎、李鹤展.社会支持与抑郁症病的相关分析[J].中国临床康复,2003,7:4108-4109。
[39]Wildes JE,Harkness KL,Simons AD.Life events,number of social realtionships,and twelve-month naturalistic course of major depression in a community samples of women.Depress Anxiety 2002;16(3):104-13.
[40]Asto c,Navarro V,Catalan R,et al.Residual symptoms in elderly major depression remitters.Acta Psychiatr Scand 2003;108(1):15-19
[1]Ross R.Atherosclerosis—an inflammatory disease.N Engl J Med 1999;340:115-126.
[2]Vorchheimer DA,Fuster V.Inflammatory marke in coronary artery disense,let prevention douse the tlames.JAMA 2001;289:2154-2156
[3]Brueckmann M,Rretsch T,Langs,et al.Time course of systemic marders of inflammation in patients presenting with acute coronary syndromes.Clin chem Lab Med 2004;42:1132-1139
[4]Miller GE,Cinnamon A,Steler RM,etal.Clinical depression and inflammatory risk markers for coronary heart disease.Am J Cardiol 2002,po:1279-1283.
[5]Edward CS,C-reactive protein is associated with psychological risk factor of cardiovascular disease in apparently health adults.Psychosom Med 2004,66:684-691
[6]Thomas AJ,Ferrier IN,Kalarin RN,et al.Cell adhesion molecule expression in the dorsolarel prefrontal cortex and anterior cingulate cortex in major depression in the elderly.Br J Psychiatry 2002;181:129-134.
[7]Dentino AN,Pieper CF,Rao KMK,et al.Association of interleukin-6 and other biological variables with depression in older people living in the community.J Am Geriatr Soc 1999;47:6-11.
[8]Fossiez F,Djossou o,chomarat P,et al.T-cell interlenkin17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.J Exp Med 1996;183:2593-2603.
[9]Aggarwal s,Ghilardi N,Xie MH,et al.Interleukin-23 promotes a distinct CD4T-cell activation state charactize by the production of interleukin-17.J Biol Chem 2003;278:1910-1914.
[10]Moseley TA,Handenschild DR,Rose L,et al.Interleukin-17 family and IL-17receptor.Cytokin Growth Factor Rev 2003;14:155-174 Survey.
[11]Empana JP,Sykes DH,Luc G,et al.Contribution of depressive mood and circulation inflammatory markers to coronaRy heart disease in healthy European men.The prospective epidemiologicd study of myocardial infarction(PRIME).Circulation,2005;111-2299-2305
[12]Hashimi S,Zeng QT.Role of interleukin-17 and interleukin-17-induced cytokines inerleukin and interleukin-8 in unstable coronary artery disease.Coronary artery disease 2006;17(8):699-706.
[13]张明园.精神科评定量表手册.长沙:湖南科学技术出版社,1993:16-222.
39.Raynes J,Eagling S,Mcadam K,Acute-phas protein synthesis in human hepatoma cell:differential regulation of serum amytoid A(SSA)and heptoglobin by Interleukin-1 and interleukin-6.Clin Exp Imunol,1999;83:488-91.
[14]Kidker PM,Rifai N,stamper MJ et al.Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.Circulation 2000:101:1767-72.
[15]Rider PM,Hennekens CH,Buring JE,Rifai N,C-reactive protein and other markers of inflammtion in the prediction of cardiovascular disease in women,N Engl J med 2000;342:836-43.
[16]Blankenberg S,Tiret L.Bickel C,et al,Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina.Circulation 2002;106:24-30.
[17]Panagiotakos DB,Pitsavos C,Chrysohoou C,et al.Inflammation,coagulation and depressive symtomatoloy in cardiovasuder disease-free people;the ATTICA study.Eur Heart J.2004;25:492-9.
[18]Suarez EC,lewis JG,Krishnan RR,et al,Enhanced expression of cytokines and chemokines by blood momocytes to in vitro lipoplysaccharide stimulation are associated with hostility and severity of depressive systoms in healthy women.Psychoneuroendocrinology 2004;29:119-28.
[19]Miller GE,Steler CA,Carney RM,Freedland KE,et al.Clinical depression and inflammatory risk markers for coronary heart disease.Am J Cardiol 2002;90:1279-83.
[20]Kop WJ ,Gottdiener JS ,Tangen-CM,et al.Inflammation and coagulation factors in persons >65years of age with symtoms of depression but without evidence of myocardial ischemia Am J cardiol 2002;89:419-24.
[21]Appels A,Bar FW,Bar J,et al.Infiammation,depressive symptomatology,and coronary artery disease.Psychosom Med 2000;62:601-5.
[22]Lesperance F,Frasure-smith N,Therous P,et al.The association between major depression and levels of soluble intercellular adhesion molecule l.interleukin,and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161:271-7.
[23]Kostulas NBS, Plidon H, Kivisakk P, et al.Increased IL-l[beta] 、 IL-8,IL-17mRNA expression in blood mononucler cells observed in a prospective ischemic stroke study. Stroke 30(10):2174-2179.
[24]Yao,z Fanslow WC,seldin MF,et al.Herpsvirus saimiri encodes a new cytokin,IL-17,which binds to a .novel cytokine receptor. Immumity 1995;3(6):811-821.
[25]Fossiez F,Djossou O,Chomarat P,et al.T cell interleukin-17 induces stromal cell to produce proinflammatory and hematopoietic cytokines.J Exp Med 1996.183(6):593-603.
[26]Moseley TA, Haudenschil OR, Rose L, et al. Interleukin-17 family and IL-17 receptors. Cytokin Growth Factor Rev 2003;14:155-174.
[27]Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated c-reative protein, Psychosom Med 2003; 65:347-356.
[28]Schins A, Tulner D, Lousberg R, et al. Inflammatory markes in depressedl post-myocardial infarction patients. J Psychiatr Res 2005;39:137-144.
[29]Michon IN, Devos P,Van Berkel T,et al. The role of IL-17 in atherosclerotic lesion formation in mice xⅢth Internation symposium on Atherosclerosis.28 september-2 October 2003 .Kyoto Japan.
[30]Michon IN,Devos P,Van wanrooij E,et al,Activation of Macrophages by IL-15 and IL-17 in atherosclerotic lesion development. ICI/FOCIS 2004.
[31]Aggarwal S,Gurney AL.IL-17:protoype member of an emerging cytokine family.J LeukinBiol 2002;71:1-8.
[32]Hata K.Andoh A,shimada M,et al.IL-17 stimulates inflammatory response via NF-[Kappa] B and MAP Kinase pathways in human colonic myofibroblasts. Am J physio Gartrointest Liver physiol 2002;282:G1035-1044.
[33]Kotake S,Udagawa N,Takahashi N,et al,IL-17 in synovial fluids from patients with rheumatoid athritis is a potent stimulator of osteoclastogenesis,J Clin Invest 1999;103:1345-1352.
[34]Falk E.Coronary thrombosis:Pathogenesis and clinical manifestations. Am J cardiol 1991;68;B28-35.
[35]Libby P Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
[36]Davies MJ.stability and instability:two faces of coronary atherosclerosis; Panl Dudley white Lecture 1995:Circulationl996;94:2013-2020.
[37]Lesperance F,Fracnre-Smith N,Theroux P,et al.The association between major depression and Levels of solube intercellalcar adhesion molecule 1 .interleukn-6 and C-reactive protein in patients with recent acute coronary syndrome .Am J Psychiatry 2004;161:271-7.
[38] Suarez EC, Lewis JG, Krishnan RR, et al. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and servity of depressive systoms in healthy women.Psycho neurendocrinology 2004;29:119-28.
[39]Smith JW, MeDonald TL. Production of serum amyloid A and c-reactive protein by Hepg2 cell stimulated with combination of cytokin of monocyte conditioned media:the effect of prednisone.Clin Exp Immunol 1992;90:293-299.
[1]杨菊贤.心理行为因素与心血管病变的发生发展[J].心血管病学进展,2001,22:295-297.
[2]黄佐,樊民,吴宗贵.冠心病患者抑郁症状与冠状动脉病变的关系[J].中国临床康复,2005,9(4):46-47.
[3]管绯,周红萍,何昆露.心理评估与健康教育对抑郁症老年冠心病患者近期预后的影响[J].中国实用医药,2007;9(2):25-27.
[4]张颖,张爱伦.老年抑郁症与冠心病[J].新疆医科大学学报,2006;29(4):371-373.
[5]Giltay EJ,Geleijnse JM,Dispositional optimison and all-case and cardiovascular mortality in a prospective cohort of elderly Dutch men and women.Original Article 2004,61(11):1126-1135.
[6]付朝伟,徐飚,栾荣生等.大城市综合医院冠心病人抑郁/焦虑影响因素探讨[J].卫生研究,2006,35(5):634-636.
[7]张亚哲,赵耕源,张书刚等.心理干预在冠心病治疗中的作用[J].中国行为医学科学,1997,6(1):39-41.
[8]李文学,张文新,付绪杰.冠心病患者伴抑郁行为心理治疗对其心绞痛和心电图的影响[J].实用药杂志,2004;21(12):1065-1607.
[9]张明圆.精神科评定量表手册[M].长沙:湖南省科学技术出版社,1993:16-222.
[10]饶中和,彭志敏.一种新的估测冠心病患者机体功能状态的调查表[J].国外医学,老年医学分册,1996;17(1):14-16.
[11]马魏,藤雅轩.认知心理干预对心绞痛患者负情情绪及心肌缺血程度的影响[J].中国临床康复,2005;9(24):25-27.
[12]Gorman JM,Sloan RP.Heart rate variability in depressive and anexity disorders.An Heart J 2000;140(4 suppl):77-83.
[13]侯云英,范秀珍.冠心病患者抑郁情绪与生活质量的相关研究[J].解放军护理杂志,2006,23(7):4-13.
[14]Feubstein RE,Blumenfield M,Orlowski B,et al.A national survey of cardiovascular physician beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.Cardiol Rev 2006;14(4):164-169
[15]Writing committee for the ENRICHD investigators.Effects of treating depression and low social support on clinical events after myocardial infarction:The enhancing recovery in coronary heart disease patients(ENRICHD) randomized trial.JAMA 2003,289:3106-16.
[16]李冬梅,心理干预对改善老年冠心病抑郁状况的临床研究[J].现代医药卫生,2006:22(9):1283-1284
[17]姚云,常丽,陈君风.心理干预对冠心病患者伴焦虑抑郁症状疗效评估[J].临床心身疾病杂志,2007;13(5):437-438.
[18]Penninx BW,Beekman ATF,Honig A,et al Depression and cardiac mortality:results from a community-based longitudinal study.Arch Gen Psychiatry 2001,58(3):221-227.
[19]许燕,张建欣.冠心病患者焦虑抑郁的心理护理[J].解放军护理杂志,2008,25(1A):32-33.
[19]Loucks EB,Berkman LF,Gruenewald TL,et al.Relation of social integration to inflammatory marker concentrations in men and women 70 tO 79 years.Am J cardiol 2006;97(7):1010-6.
[20]Abraham AA,Mary H,Caherine MT,et al.Depression systoms and risk of coronary heart disease and mortality in elderly Americans.Circulation 2000;102:1773-9.
[20]Blumenthal JA,Babyak M,Wei J,et al.Usefulness of psychosociat treatment of mental stress-induced myocardial ischemia in men.Am J Cardiol 2002;89:164-8.
[1]Kop WJ,Ader DN.Assessment and treatment of depression in coronary artery disease patients.Ital Heart J 2001;2(12):890-4...
[2]Schleifer SJ,Macari-Hinson MM,Coyle DA,et al.The nature and course of depression following myocardial infarction.Ach Intern Med 1989;149:1785-9
[3]Thornton LA.depression in post-acuate myocardial infarction patients.J Am Acad Nurse Pract 2001;13(8):364-7
[4]黄佐,樊民,吴宗贵。冠心病患者抑郁与冠状动脉病变的关系,中华心血管 病杂志,2003;31(5):329
[5]雍生满,周保,栾红等。住院冠心病人焦虑抑郁症状的调查,宁夏医学杂志,2006:28(8):606-607
[6]Roseyren A,Hawken S,ounpuu S,et al.Effect of psychosocial risk factors with risk of acute myocardial infarction in 1119 cases and 13468 controt fron 52 co untries C the INTERHEART study):case-control study[J].Lancet,2004,364:953-P62.
[7].Abraham AA,Mary H,Catherine MT,et al.Depression systoms and risk of coronary heart disease and mortality in elderly Americans.Circulation.2000;102:1773-9
[8]Barefoot JC,Helm S Mark DB,et al.Depression and long-term mortality risk in patients with coronary artery disease.Am J Cardiol 1996;78(6):613-7
[9]O'Mally PG;JonesDI,Feuentein IM et al.Lake of correlation between psychological factors and subclinical coronary artery disease.Am J Heart.2000;86:1135-8
[10]吴京兰,苏又苏,付剑云等。老年冠心病患者抑郁程度与心肌缺血的关系,中国康复理论与实践,2005;11(1):51-52
[11]周成刚,任寰,曾火飚等。农村社区冠心病并发抑郁发生率和相关因素的研究,现代预防医学,2006;36(6):877
[12]Lesperance F,Frasure-Smith N,Theroux P,et al.The association betweem major depressiom and levels of selubte cellutlar adhesion moleculei,interleukin-6,and c-reactive protein in prtients with recent acute coronary syndromes.Am J p sychiatry,2004,161:271-277
[13]Miller GE,Freedland KE,Duntley S,at el.Relation of depressioe symptoms to c-reuctive protein and pathoyen burden c cytomegalovirus,herpes wimplex virus Dpstein-Barr virus)in patients with earlier acute coronary syndromes.Am J cardiot,2005.95:317-321
[14]Schis A,Tulner D,Lousberg R,et al.Infcammatory markers in depressed post-myocardial infarction patients.J Psychiatrn,Res,2005,39:137-144
[15]Miler GE,Stetler CA,Carney RM,et al.Clinical depression and inflammatory risk markers for coronary heart disease.AM J Cardiol,2002,90:1279-1283
[16]Pender R,Pories WJ,Epidemiology of obesity in the Unite States.Gastroenterol Clin North Am:2005,34(1):1-7
[17]Lee RS,Kim YH,Beck BH,et al.Depression mood and abdominal fat distribution in overweight preneopasual women.Obes Res,2005;13(2):320-325
[18]Wellen KE,Hotanisligil GS.Inflammation,stress and diabetes.J Clin Invest,2005;115(5):1111-1119
[19]Hjerkinn EM,Seljeflkt I,Ellingsen I,et al,Intluence of long-term interventim with dietary counseling,ling-chinn-3 fatty acid supple ments,or both on cirulation markers of endothelial activation in men with ling-standing typerlipidemia,Sm F Clin Nutr,2005,81:583-589.
[20]Vigo DE,Nicola Sift L,Ladron De Guevara MS et al.Relation of depression to heart rate nonlinear dynamics in patients≥60 years of age with recent unstable angina pectoris or acuate myocardial infarction patients.Am J Cardiol,2004;93:756-760
[21]Drago S,Berggrone S,Anselmino M,et al,Depression in patients with acute myocardial infarction:Influence on autonomic mervous system and prognostic role:Results of a five year follow up study.Int J Cardiol,2007,115(1):46-51
[22]Vonkannel R.Platelet hyperactivity in clinincal depression and the beneficial dffect of antidepressiont druy treatment:How strong is the evidenc.Acta pcychiatr scand,2004,110:163-177.
23.Sherwood A,Hinderliter AL,watkins LL,et al.Impaired endothelial function in coronary teart disease patieuts with depressive symptomology,J Am cardial.2005,46:656-659.
25.Mccaffery JM,Fracur-smith N,Dube MP,et al,commom genetic vulneralility to depressive symptoms and coronary artery disease.A review and development of candidate genes related to intlammaiton and sterotinin psychosom Med,2006,68:187-200.
[26]Nakatani D,Sato H,sarata R,et al,influence of serotomin transporter gene polymorphism on depressive xymptoms and new cardioc events after acute myocardial infarction,Am Heart J 2005,150:652-658.
[27]付朝伟,徐飚,栾荣生等。大城市综合医院冠心病人抑郁/焦虑影响因素探讨, 卫生研究,2006;35(5):634-636
[28]徐为民,冯丽。冠心病与感染和抑郁的关系,中国社区医师,2004;20(18):35
[29]Loucks EB,Berkman LF,Gruenewald TL,et al,Relation of social integration to inflammatory marker concentrations in men andwomen 70 to 79 years.Am J Cardiol.2006;97(7):1010-6.Epub 2006 Feb 20.
[1] Jiang W, Glassman A, Krishnan R, et al. Depression and ischemic heart disease: what have we learned so far and what must we do in the future? Am Heart J 2005; 150:54-78.
[2] Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217.
[3] Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality:results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
[4] Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998;158:1422-6.
[5] Stansfeld S, Fuhrer R. Depression and coronary heart disease. In: Stansfeld S,Marmot M, eds. Stress and the heart. London: BMJ Books, 2002:101-23.
[6] Stansfeld SA, Fuhrer R, Shipley MJ, et al. Psychological distress as a risk factor for coronary heart disease in the Whitehall Ⅱ study. Int J Epidemiol 2002;31:248-55.
[7]Empana JP, Jouven X, Lemaitre RN, et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med 2006; 166:195-200.
[8]Shimbo D, Davidson KW, Hass DC, et al. Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, future directions. J Thromb Haemost 2005; 3:897-908.
[9]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
[10].Naghavi M, Libby P, Falk E,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72.
[11]Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
[12]Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease:is there a link? Lancet 1997;350:430-6.
[13]Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
[14]Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
[15]Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study.Circulation 1997;96:4219-25.
[16]Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
[17]Ozeren A, Aydin M, Tokac M, et al. Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris. Mediators Inflamm 2003;12:361-5.
[18]Fang L, Wei H, Mak KH,et al. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease. Can J Cardiol 2004;20:1433-8.
[19]Hajilooi M, Sanati A, Ahmadieh A, Ghofraniha A, Massoud A. Circulating ICAM-1, VCAM-1, E-selectin, P-selectin, and TNFRⅡ in patients with coronary artery disease. Immunol Invest 2004;33:263-75.
[20]Tracy RP. Inflammation, the metabolic syndrome and cardiovascular risk.Int J Clin Pract Suppl 2003;10-7.
[21]Lindmark E, Diderholm E, Wallentin L, et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001;286:2107-13.
[22]Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
[23]Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002;39:1133-8.
[24]Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001;104:1336-42.
[25].Miller GE, Stetler CA, Carney RM, et al. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-83
[26].Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56
[27]Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression and CRP in patients with recent acute coronary syndromes. In Preparation.
[28]Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression, sICAM-1, interleukin-6 and CRP in patients with recent acute coronary syndromes. Am J Psychiatry; in Press.
[29]Rajagopalan S, Brook R, Rubenfire M, et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196.
[30]Bluthe RM, Laye S, Michaud B,et al. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: A study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 2000;12:4447-56.
[31]Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med 1999;61:476-87.
[32]Kop WJ, Cohen N. Psychological risk factors and immune system involvement in cardiovascular disease. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001:525-44.
[33]Kop WJ, Ader DN. Assessment and treatment of depression in coronary artery disease patients. Ital Heart J 2001;2:890-4.
[34]Kop WJ, Appels A, Mendes de Leon CF, et al. The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res 1996;40:397-405.
[35]Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
[36]Goodkin K, Appels A. Behavioral-neuroendocrine-immunologic interactions in myocardial infarction. Med Hypotheses 1997;48:209-14.
[37]Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
[38]Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 1989;44:1995-2008.
[39]Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 2005;29:891-909.
[40]Capuron L, Ravaud A, Miller AH, Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun2004;18:205-13.
[41]Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S,Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001;344:961-6.